109 related articles for article (PubMed ID: 2724074)
1. Microbial models of mammalian metabolism: conversion of warfarin to 4'-hydroxywarfarin using Cunninghamella bainieri.
Rizzo JD; Davis PJ
J Pharm Sci; 1989 Mar; 78(3):183-9. PubMed ID: 2724074
[TBL] [Abstract][Full Text] [Related]
2. Microbial models of mammalian metabolism: production of 3'-hydroxywarfarin, a new metabolite of warfarin using Cunninghamella elegans.
Wong YW; Davis PJ
J Pharm Sci; 1991 Apr; 80(4):305-8. PubMed ID: 1865328
[TBL] [Abstract][Full Text] [Related]
3. Microbial models of mammalian metabolism: stereoselective metabolism of warfarin in the fungus Cunninghamella elegans.
Wong YW; Davis PJ
Pharm Res; 1989 Nov; 6(11):982-7. PubMed ID: 2594692
[TBL] [Abstract][Full Text] [Related]
4. Substrate probe for the mechanism of aromatic hydroxylation catalyzed by cytochrome P450.
Darbyshire JF; Iyer KR; Grogan J; Korzekwa KR; Trager WF
Drug Metab Dispos; 1996 Sep; 24(9):1038-45. PubMed ID: 8886617
[TBL] [Abstract][Full Text] [Related]
5. Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19.
Wienkers LC; Wurden CJ; Storch E; Kunze KL; Rettie AE; Trager WF
Drug Metab Dispos; 1996 May; 24(5):610-4. PubMed ID: 8723744
[TBL] [Abstract][Full Text] [Related]
6. Phase II metabolism of warfarin in primary culture of adult rat hepatocytes.
Jansing RL; Chao ES; Kaminsky LS
Mol Pharmacol; 1992 Jan; 41(1):209-15. PubMed ID: 1732719
[TBL] [Abstract][Full Text] [Related]
7. Substrate probes for the mechanism of aromatic hydroxylation catalyzed by cytochrome P-450: selectively deuterated analogues of warfarin.
Bush ED; Trager WF
J Med Chem; 1985 Aug; 28(8):992-6. PubMed ID: 4020838
[TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon hydroxylase activity in the fungus Cunninghamella bainieri: evidence for the presence of cytochrome P-450.
Ferris JP; MacDonald LH; Patrie MA; Martin MA
Arch Biochem Biophys; 1976 Aug; 175(2):443-52. PubMed ID: 8708
[No Abstract] [Full Text] [Related]
9. Biotransformation of amitriptyline by Cunninghamella elegans.
Zhang D; Evans FE; Freeman JP; Duhart B; Cerniglia CE
Drug Metab Dispos; 1995 Dec; 23(12):1417-25. PubMed ID: 8689954
[TBL] [Abstract][Full Text] [Related]
10. Microbial models of mammalian metabolism. Biotransformations of N-methylcarbazole using the fungus Cunninghamella echinulata.
Yang W; Davis PJ
Drug Metab Dispos; 1992; 20(1):38-46. PubMed ID: 1346994
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of warfarin and 7-hydroxywarfarin enantiomers by high-performance liquid chromatography with ultraviolet detection.
Miura M; Okuyama S; Kato S; Kagaya H; Murata A; Komatsuda A; Wakui H; Sawada K
Ther Drug Monit; 2011 Feb; 33(1):108-14. PubMed ID: 21157402
[TBL] [Abstract][Full Text] [Related]
12. In vitro stimulation of warfarin metabolism by quinidine: increases in the formation of 4'- and 10-hydroxywarfarin.
Ngui JS; Chen Q; Shou M; Wang RW; Stearns RA; Baillie TA; Tang W
Drug Metab Dispos; 2001 Jun; 29(6):877-86. PubMed ID: 11353757
[TBL] [Abstract][Full Text] [Related]
13. Chemical synthesis, absolute configuration, and stereochemistry of formation of 10-hydroxywarfarin: a major oxidative metabolite of (+)-(R)-warfarin from hepatic microsomal preparations.
Lawrence RF; Rettie AE; Eddy AC; Trager WF
Chirality; 1990; 2(2):96-105. PubMed ID: 2400642
[TBL] [Abstract][Full Text] [Related]
14. Microbial models of mammalian metabolism: involvement of cytochrome P450 in the N-demethylation of N-methylcarbazole by Cunninghamella echinulata.
Yang W; Jiang T; Acosta D; Davis PJ
Xenobiotica; 1993 Sep; 23(9):973-82. PubMed ID: 8291265
[TBL] [Abstract][Full Text] [Related]
15. Fungal transformations of antihistamines: metabolism of cyproheptadine hydrochloride by Cunninghamella elegans.
Zhang D; Hansen EB; Deck J; Heinze TM; Henderson A; Korfmacher WA; Cerniglia CE
Xenobiotica; 1997 Mar; 27(3):301-15. PubMed ID: 9141237
[TBL] [Abstract][Full Text] [Related]
16. Biotransformation of aryl alkylamines by Cunninghamella bainieri.
Foster BC; Coutts RT; Pasutto FM
Xenobiotica; 1989 May; 19(5):531-8. PubMed ID: 2750209
[TBL] [Abstract][Full Text] [Related]
17. Disposition of drugs in cystic fibrosis. VI. In vivo activity of cytochrome P450 isoforms involved in the metabolism of (R)-warfarin (including P450 3A4) is not enhanced in cystic fibrosis.
Wang JP; Unadkat JD; McNamara S; O'Sullivan TA; Smith AL; Trager WF; Ramsey B
Clin Pharmacol Ther; 1994 May; 55(5):528-34. PubMed ID: 8181197
[TBL] [Abstract][Full Text] [Related]
18. Quantitative liquid chromatography/mass spectrometry/mass spectrometry warfarin assay for in vitro cytochrome P450 studies.
Zhang ZY; King BM; Wong YN
Anal Biochem; 2001 Nov; 298(1):40-9. PubMed ID: 11673893
[TBL] [Abstract][Full Text] [Related]
19. The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study.
Gemmati D; Burini F; Talarico A; Fabbri M; Bertocco C; Vigliano M; Moratelli S; Cuneo A; Serino ML; Avato FM; Tisato V; Gaudio RM
PLoS One; 2016; 11(9):e0162084. PubMed ID: 27606428
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of the warfarin-rifampin drug interaction in humans.
Heimark LD; Gibaldi M; Trager WF; O'Reilly RA; Goulart DA
Clin Pharmacol Ther; 1987 Oct; 42(4):388-94. PubMed ID: 3665337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
